What are the recommended oral antibiotics for uncomplicated urinary tract infections (UTIs) in men?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: August 5, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Oral Antibiotics for UTI in Men

For uncomplicated urinary tract infections (UTIs) in men, a 14-day course of fluoroquinolones (ciprofloxacin 500-750 mg twice daily or levofloxacin 750 mg once daily) is recommended as first-line therapy when local fluoroquinolone resistance is <10%. 1

First-Line Treatment Options

When selecting an oral antibiotic for UTIs in men, consider the following options:

  1. Fluoroquinolones (when local resistance <10%):

    • Ciprofloxacin: 500-750 mg twice daily for 14 days
    • Levofloxacin: 750 mg once daily for 14 days
  2. Alternative options:

    • Trimethoprim-sulfamethoxazole (TMP-SMX): 160/800 mg twice daily for 14 days

Important Considerations

  • All UTIs in men are considered complicated: According to the European Association of Urology guidelines, male gender is a factor that classifies UTIs as complicated 2
  • Treatment duration: A 14-day course is generally recommended for men, particularly when prostatitis cannot be excluded 2, 1
  • Urine culture: Always obtain a urine culture before initiating antibiotics to guide therapy 1
  • Resistance patterns: Consider local resistance patterns when selecting empiric therapy 1

Special Situations

Renal Impairment

If using levofloxacin in patients with impaired renal function, adjust dosing based on creatinine clearance:

  • ≥50 mL/min: 750 mg once daily (normal dose)
  • 20-49 mL/min: 500 mg once daily
  • 10-19 mL/min: 250 mg once daily
  • Hemodialysis or Peritoneal Dialysis: 250-500 mg every 48 hours (dose post-HD on dialysis days) 1

Multidrug-Resistant Organisms

For patients at risk of infections with extended-spectrum β-lactamases (ESBLs)-producing organisms:

  • Avoid empiric use of TMP-SMX and fluoroquinolones if patient was recently exposed to these agents 3
  • Consider alternative agents based on susceptibility testing

Monitoring and Follow-up

  • Assess clinical response within 48-72 hours of initiating therapy
  • Perform follow-up urine culture 1-2 weeks after completing treatment if symptoms persist 1
  • Consider urological evaluation for structural abnormalities in men with recurrent UTIs 1

Common Pitfalls to Avoid

  • Treating for too short a duration: Male UTIs require longer treatment (14 days) compared to uncomplicated UTIs in women 1
  • Not obtaining urine cultures: Always collect cultures before starting antibiotics 1
  • Overlooking prostatitis: Consider the possibility of concurrent prostatitis in male UTIs 1
  • Ignoring local resistance patterns: Local antibiotic resistance should guide empiric therapy choices 2, 1

By following these guidelines, clinicians can optimize treatment outcomes and reduce the risk of complications and recurrence in men with UTIs.

References

Guideline

Urinary Tract Infections

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.